The advantages of the present experimental approach are three-fold: First, in the single cell–based assay system, the Ca2+-induced Ca2+ release (37) through RyR1 mutants can directly be quantified without taking into consideration myopathy development (15, , , –19, 36, 38, , , , , –44). The gene discussed is RYR1; the disease is myopathy.